Share This

Related Topics News -

     
 Detail   |   Print 
     
《業績》昭衍新藥首季度虧損2.72億人民幣 盈轉虧
2024-04-30T  
《大行》里昂升泰格醫藥及昭衍新藥評級至「跑贏大市」 上調目標價
2024-04-11T  
《公司業績》昭衍新藥全年純利3.97億人民幣跌63% 末期息派16分
2024-04-02T  
《大行報告》野村:美參議院法案消息或令內地CRO板塊的投資者情緒惡化
2024-03-07T  
昭衍新藥主席夫婦被中證監指減持未有及時披露
2024-02-09T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.